Home › Trials › NCT00031408

Consent for using stored patient samples for future testing

Plan for Obtaining Informed Consent to Use Stored Human Biological Materials (HBM) for Currently Unspecified Analyses

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections · NCT00031408

This study is asking patients if they agree to let researchers use their leftover blood and tissue samples for future HIV research to help improve understanding and treatment of the disease.

Quick facts

Study typeObservational
Enrollment30000 (estimated)
SexAll
SponsorAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (network)
Locations63 sites (Los Angeles, California and 62 other locations)
Trial IDNCT00031408 on ClinicalTrials.gov

What this trial studies

This study aims to obtain informed consent from patients to use their stored human biological materials, such as blood and tissues, for future research, including genetic testing related to HIV. Participants will be asked to consent to the use of leftover samples from previous clinical trials and to provide a blood sample for DNA archiving. The goal is to enhance the understanding of HIV disease and improve its management by allowing researchers access to archived samples for unspecified analyses. Participation does not affect involvement in other clinical trials.

Who should consider this trial

Good fit: Ideal candidates are individuals currently participating in or who have previously participated in an AACTG clinical trial.

Not a fit: Patients who do not wish to consent to the use of their biological materials for future testing will not benefit from this study.

Why it matters

Potential benefit: If successful, this could lead to improved understanding and management of HIV infections through future research utilizing stored biological materials.

How similar studies have performed: Other studies utilizing stored biological materials for research have shown success, indicating that this approach is supported by prior findings.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* Parent or guardian willing to give informed consent, if applicable
* Either currently participating in or have ever participated in an AACTG clinical trial

Where this trial is running

Los Angeles, California and 62 other locations

+13 more sites — see ClinicalTrials.gov for the full list.

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: HIV Infections, Specimen Handling, Blood, Informed Consent, Genetic Screening

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.